Sharon Bio - Medicine Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported revenue was INR 560.19 million compared to INR 458.5 million a year ago. Net income was INR 88.46 million compared to INR 44.77 million a year ago. Basic earnings per share from continuing operations was INR 15.37 compared to INR 7.78 a year ago.
For the six months, revenue was INR 945.73 million compared to INR 953.94 million a year ago. Net income was INR 77.35 million compared to INR 89.71 million a year ago. Basic earnings per share from continuing operations was INR 13.44 compared to INR 15.59 a year ago.